May 28, 2026 · Form 4 insider transaction
Lichtenstein Chen bought 7,242 shares of Teva Pharmaceutical Industries Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.; Restricted share units were granted on May 28, 2026 and vest on May 28, 2027.; The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.